- 702022 - Invitrogen Antibodies RBFOX3 antibody

Submitted references Molecular Markers of Mechanosensation in Glycinergic Neurons in the Avian Lumbosacral Spinal Cord.

Stanchak KE, Miller KE, Lumsden EW, Shikiar D, Davis C, Brunton BW, Perkel DJ
eNeuro 2022 Sep-Oct;9(5)

Aberrant crosstalk between insulin signaling and mTOR in young Down syndrome individuals revealed by neuronal-derived extracellular vesicles.

Perluigi M, Picca A, Montanari E, Calvani R, Marini F, Matassa R, Tramutola A, Villani A, Familiari G, Domenico FD, Butterfield DA, Oh KJ, Marzetti E, Valentini D, Barone E
Alzheimer's & dementia : the journal of the Alzheimer's Association 2022 Aug;18(8):1498-1510

Small molecules efficiently reprogram apical papilla stem cells into neuron-like cells.

Chen Q, Yuan C, Jiang S, Heng BC, Zou T, Shen Z, Wang P, Zhang C
Experimental and therapeutic medicine 2021 Jun;21(6):546

Developmental Regulation of Homeostatic Plasticity in Mouse Primary Visual Cortex.

Wen W, Turrigiano GG
The Journal of neuroscience : the official journal of the Society for Neuroscience 2021 Dec 1;41(48):9891-9905

Ultrashort Wave Combined with Human Umbilical Cord Mesenchymal Stem Cell (HUC-MSC) Transplantation Inhibits NLRP3 Inflammasome and Improves Spinal Cord Injury via MK2/TTP Signalling Pathway.

Na L, Wang S, Liu T, Zhang L
BioMed research international 2020;2020:3021750

Fgr contributes to hemorrhage-induced thalamic pain by activating NF-κB/ERK1/2 pathways.

Huang T, Fu G, Gao J, Zhang Y, Cai W, Wu S, Jia S, Xia S, Bachmann T, Bekker A, Tao YX
JCI insight 2020 Oct 15;5(20)

Inflammasome Activation Induces Pyroptosis in the Retina Exposed to Ocular Hypertension Injury.

Pronin A, Pham D, An W, Dvoriantchikova G, Reshetnikova G, Qiao J, Kozhekbaeva Z, Reiser AE, Slepak VZ, Shestopalov VI
Frontiers in molecular neuroscience 2019;12:36

Gemfibrozil, a Lipid-Lowering Drug, Lowers Amyloid Plaque Pathology and Enhances Memory in a Mouse Model of Alzheimer's Disease via Peroxisome Proliferator-Activated Receptor α.

Chandra S, Pahan K
Journal of Alzheimer's disease reports 2019 May 18;3(1):149-168

No comments: Submit comment

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Immunofluorescence was performed on fixed and permeabilized SH-SY5Y cells for detection of endogenous Fox3 using Anti- Fox3 Recombinant Rabbit Monoclonal Antibody (Product # 702022, 2 µg/mL) and labeled with Goat anti-Rabbit IgG (H+L) Superclonal™ Secondary Antibody, Alexa Fluor® 488 conjugate (Product # A27034, 1:2000). Panel a) shows representative cells that were stained for detection and localization of Fox3 protein (green), Panel b) is stained for nuclei (blue) using SlowFade® Gold Antifade Mountant with DAPI (Product # S36938). Panel c) represents cytoskeletal F-actin staining using Alexa Fluor® 555 Rhodamine Phalloidin (Product # R415, 1:300). Panel d) is a composite image of Panels a, b and c clearly demonstrating nuclear localization of Fox3. Panel e) represents control cells with no primary antibody to assess background.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Flow Cytometry analysis of Fox3 was performed on SH-SY5Y cells labeled with ABfinity™ Anti-Fox3 Recombinant Rabbit Monoclonal Antibody (Product# 702022, 5 ug/ 1M cells) or with rabbit isotype control at 0.5 ug/ml and detected with Goat anti-Rabbit IgG (H+L) Superclonal™ Secondary Antibody, (Alexa Fluor® 488 conjugate, Product # A27034, 0.4 ug/ml, 1:2500) as represented by the red and pink histograms respectively. The purple histogram represents unstained control cells and the green histogram represents no-primary-antibody control. A representative of 10,000 cells were acquired and analyzed for each sample using an Attune® Acoustic Focusing Cytometer (4468770).

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: RNA immunoprecipitation (RIP) western of RBFOX3 was performed on K562 cells. Antigen-antibody complexes were formed by incubating approximately 500 µg whole cell lysate with 5 µg of RBFOX3 monoclonal antibody (Product # 702022) rotating 60 min at RT. The immune complexes were captured on 625 µg of anti- rabbit coated Dynabeads (Product # 11204D), washed extensively, and eluted with NuPAGE™ LDS Sample Buffer (Product # NP0007). Samples were resolved onto NuPAGE™ 4-12% Bis-Tris gel (Product # NP0335BOX). Lanes 1 and 3 are input and lanes 2 and 4 are IP. Proteins were transferred to PVDF membrane (Product # IB23001). Membrane was blocked in 5% milk. Target was detected using a RBFOX3 monoclonal antibody (Product # 702022) at a dilution of 1:2000, followed by a 1:4000 dilution of secondary antibody. Chemiluminescent detection was performed using ECL Western Blotting Substrate (Product # 32106). Data courtesy of the Yeo lab as part of the ENCODE project (www.encodeproject.org).

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: RNA immunoprecipitation (RIP) western of RBFOX3 was performed on K562 cells. Antigen-antibody complexes were formed by incubating approximately 500 µg whole cell lysate with 5 µg of RBFOX3 monoclonal antibody (Product # 702022) rotating 60 min at RT. The immune complexes were captured on 625 µg of anti- rabbit coated Dynabeads (Product # 11204D), washed extensively, and eluted with NuPAGE™ LDS Sample Buffer (Product # NP0007). Samples were resolved onto NuPAGE™ 4-12% Bis-Tris gel (Product # NP0335BOX). Lanes 1 and 3 are input and lanes 2 and 4 are IP. Proteins were transferred to PVDF membrane (Product # IB23001). Membrane was blocked in 5% milk. Target was detected using a RBFOX3 monoclonal antibody (Product # 702022) at a dilution of 1:2000, followed by a 1:4000 dilution of secondary antibody. Chemiluminescent detection was performed using ECL Western Blotting Substrate (Product # 32106). Data courtesy of the Yeo lab as part of the ENCODE project (www.encodeproject.org).

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Figure 1 Combination therapy improves motor functions and reduces spinal cord injury in SCI rats. (a) Evaluated BBB scores in each group of rats in different time-points (preoperation, 1 d, 1 w, 2 w, and 4 w). (b) Histopathological changes in SCI rats treated with monotherapies of USW and HUC-MSCs, respectively, and combination therapy were observed with HE and Nissl staining (scale bar = 50 mu m). (c) Expression level of NeuN detected with IF (scale bar = 50 mu m); percentage of NeuN positive cells was calculated and represented in bar chart attached. "" * , #, &"" indicated significant difference ( p < 0.05), "" * "" vs. Sham group, ""#"" vs. SCI group, and ""&"" vs. rats treated with monotherapy (USW/HUC-MSCs).

702022

Antibody data